Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

06/09/20 aa Transderm Scopalamine Patches: Description Update
June 9, 2020

From: "Aaron Atkins" <aaron.atkins@hhsys.org>
To: "Pharmacy Department" <grp_pharmacy@hhsys.org>
Sent: Tuesday, June 9, 2020 10:29:56 AM
Subject: Transderm Scopalamine Patches: Description Update

The labelling for the Transderm Scopalamine 1.5 mg patch is changing to indicate the dose delivered of  1 mg/3 days. 

Note that the patch still contains scopolamine 1.5 mg base, but it is meant to only deliver 1 mg over 72 hours.

We will be updating descriptions in Carousel/Pyxis/Cerner to reflect the new emphasis of “Delivers: 1 mg/72 hrs.”  Please let us know if you have any questions/concerns.

 






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved